Hot Investor Mandate 1: Healthcare & Real Estate Fund Makes Seed-Series B Biotech & Medtech Investments

A holding company with offices in China and the USA aims to serve human healthcare and technological development through high-tech investment and real estate investment. Through its investment arm the firm makes venture investments in healthcare. Typical allocations range from US$1-10 million in companies from Seed to Series B stages. The firm is open to leading or following in a round. The firm is looking for opportunities from US and Canada that have a China angle.

Within healthcare, the firm considers biopharmaceuticals, medical devices, diagnostics, and AR/VR/AI innovations in healthcare. The firm is focused on diseases with large market potential including oncology, infectious disease, diabetes, CNS, and cardiovascular diseases. The firm is opportunistic in terms of stage of development and typically participates in Seed to Series B rounds.

The firm is seeking innovative products and can aid with management, operations, and registration. Leveraging its resources in China, the firm can facilitate distribution in the China market. However, distribution rights are not a requirement for investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Hot Investor Mandate 2: China VC Raises New Fund For US Life Science Deals

A venture capital firm based in China has over $2 billion in total managed assets in the areas of healthcare, technology and internet, and clean tech.  The firm invests from both a USD fund and an RMB fund, and is raising a new US fund in 2017.  The firm has invested in more than 50 healthcare companies, that span most sectors of life sciences from pharmaceuticals and medical devices to healthcare IT, diagnostics and select healthcare services. The firm intends to lead, co-lead, or co-invest in US-based private companies with equity investments ranging from $3 to $12 million.

The firm is open to many sectors in the life science space – biotech therapeutics, medical devices, diagnostics, and healthcare IT. The firm is most interested in breakthrough products and technologies that address a large unmet need. The firm seeks investments in 510K devices and we will invest in devices in the PMA pathway depending on stage, preferably clinical or later. In therapeutics, the firm is modality-agnostic, but generally seeking opportunities that are past the pre-clinical stage. The firm is also interested in enabling technologies for drug discovery and development, and other healthcare-related technologies in the “digital-health” space.

The firm is seeking to invest in companies with novel ideas and technology and experienced and passionate management. Given the firm’s slogan of “inspiring people with the wisdom to succeed with diligence”, The firm’s team is “hands-on” and typically assumes a board seat after an investment.  Investments in US companies are expected to have upside opportunities in China, and can leverage our China network and expertise.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Hot Investor Mandate 3: Advanced Materials Corporation Invests in Drug Discovery Tech, Precision & Cell Based Medicine, IVDs and Medtech

A chemical and polymer manufacturer is vigorously looking to expand its business into life sciences and seeking for inorganic growth vehicles through strategic investments and acquisitions that reinforce the company’s core competencies.

The company is interested in CDMOs for the biologics field and CRO to support new drug discovery process of pharmaceutical industry.  In addition to this, the firm is looking for disruptive technologies in the fields of precision medicine, stem cell biology & cell-based medicine, Microbiome, designed medical devices and In Vitro Diagnostics.

As for CDMO, startups which have unique value proposition for the pharmaceutical industry are of interest. Regarding CROs, the firm is interested in companies based in Europe or North America with positive operating income. For other technologies, the firm would like to contact startups with at least proof of concept and strong IP. The firm is interested in co-development of these technologies, co-distribution of the product offerings and sharing of profit based on the contribution from each player.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Hot Investor Mandate 4: China-based Pharma Seeks Early Stage Investments in Drugs, Nutraceuticals and Digital Health

A publicly traded pharma corporation based in China is actively pursuing strategic partnerships with other pharmaceutical companies, natural product producers, universities, hospitals and researchers and developers. The firm considers a board range of strategies including investment, joint venture, acquisition, licensing, and development funding. The firm is looking for opportunities in North America and Europe.

The firm is looking for strategic partnerships in prescription drugs, nutraceuticals, and digital health. Other sectors of interest include healthcare services, children’s health education, and senior care. The firm is open to products at all development stages. Within biopharmaceuticals, the firm takes an opportunistic approach to small molecules, biologics, and other modalities. Within digital health, the firm is looking for products that are complimentary to its pipeline.

The firm is looking to build collaborative partnerships with experienced teams in key strategic sectors. The firm can provide US regulatory expertise, global operation, and distribution channels and clinical trial sites across China.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Caveat Emptor When Signing Up for Family Office Conferences

By Lucy Parkinson, Director of Research, LSN

If you’re the CEO of an early stage life science company, you’re most likely attending a lot of events in order to find investors and strategic partners. Due to the long term capital needs in this sector, there’s a particularly high interest in family office conferences as a potential source of funding. However, from LSN staff attending many of these events and also hearing from LSN clients we’ve discovered that many of these events are not always as advertised. Buyer beware when checking out an event. Watch out for the following warning signs:

Flood of Consultants. Seeing a lot of names of advisory or consulting firms in the attendee list of a conference you are looking to attend is an obvious red flag. The main point of partnering conferences for early-stage companies is to connect with as many relevant investors as possible. Pitching to firms that do not directly allocate capital is not an efficient use of anyone’s time.

Not Life Science Investors. Let’s say that there’s a good number of real investors at a particular event. How many of them invest mainly in life sciences companies? We see events that claim to help early-stage life science companies acquire capital, only to notice that many investors are not even in the life sciences sector. Unfortunately, this phenomenon happens quite frequently when events are organized by groups that lack the life sciences expertise.

Lack of Focus on Private Venture Financing. Another aspect that these events often fall short on is their lack of focus on private investors. Most early stage companies are launched by private investment. Meeting public focused investors can be a nonstarter.

Lack of a Global Outlook. Conferences dedicated to a local regional focus can be fine, but having both regional and global players is exponentially better. Look for conferences that encourage a global perspective. Especially with the emerging investor market in Asia, a global outlook presents additional opportunities.

Topic Focus. Look for conferences that are dedicated to fundraising and networking. A general life science conference will have too many speakers and topics that just aren’t relevant to raising capital. Instead, look for conferences that seek to help you make the connections and provide the fundraising opportunities that you need.

Networking Time and Partnering Opportunities: Some events claim to be networking and partnership conferences, yet they fail to set aside more than an hour for dedicated networking and partnering. If you’re looking to network at these events, make sure there’s actually enough time set aside for networking to occur. LSN has been involved with both single and multi-family offices for five years, and our staff have been to many “Family Office Conferences”. Mostly what you will find is a lot of service providers and financial consultants. Typically family offices prefer to stay off the radar screen. They are easily inundated with requests and ideas. Instead, they prefer to find one firm they like and trust and then stick with that firm for their deal sourcing needs – and it’s typically not a “Family Office Conference” provider.

LSN works with 250 family offices, about a third of whom are actively investing in life science and have provided us with an investment mandate. A subset of these family offices ask LSN to filter and funnel companies that meet their criteria directly to the family office. We draw upon these relationships to present our Family Office panels at RESI. To achieve this, LSN has had to learn the family office marketplace in depth. It’s a slippery path, because everyone thinks it’s a good idea to target a family office for capital for their idea du jour, which makes the family offices go further off the radar as they can get easily inundated. Family Offices are in the mix when it comes to early stage investments and so are the other 9 categories of investors. To find an investor that’s fit for your stage of development and product or service, you’ll need to seek out conferences that provide actual investors and dynamic partnering.

 

Fundraising Bootcamp Video: A Must-Watch for CEOs Contemplating Raising Capital

By Nono Hu, Director of Marketing, LSN

At the 12th Annual Non-Dilutive Funding Summit on January 11th, Dennis Ford gave a Fundraising Bootcamp presentation for early stage life science CEOs.  We’re now delighted to make this presentation available online.  Covering topics from branding and messaging for your company to positioning yourself to raise capital, the Fundraising Bootcamp is invaluable to CEOs seeking financing to move their technologies forward in the development process.

Discounted Rates for Hotel and Travel at RESI on MaRS

By Natasha Eldridge, RESI Conference Manager, LSN

natasha-wp-newThe 2017 RESI on MaRS conference is proud to be partnering with hotels and airlines to offer attendees exclusive discounts during their stay in Toronto.

Porter Airlines and Air Canada are both offering discounts on flights to Toronto for flights scheduled from April 1 – 8, 2017. The Fairmount Royal York Hotel is also offering discounts from April 3 – 5, 2017. Additional hotel partners include Sheraton Centre Toronto and Chelsea Hotel.

Included are the promo codes and links to our RESI on MaRS partners and we look forward to seeing you in Toronto.

hotelFairmont Royal York
Address: 100 Front St W, Toronto, ON M5J 1E3, Canada
Phone: +1 416-368-2511
Rate for RESI on MaRS Attendees (Apr. 3 – Apr. 5)

Book Now

 

Sheraton Centre Toronto
Address: 123 Queen St W, Toronto, ON M5H 2M9, Canada
Phone: +1 416-361-1000

Book Now

 

Chelsea Hotel
Address: 33 Gerrard St W, Toronto, ON M5G 1Z4, Canada
Phone: +1 416-595-1975

Book Now

 

porterPorter Airlines is proud to offer a 10% discount on available base fares (with the exception of the lowest class fare during a public seat sale) for travel to and from the MaRS Health Investors Conference. Please book online here or through your travel agent using promo code MARS17. The discounted fares are available for booking from December 22, 2016 to April 8, 2017 and available for travel:

 

Location: Dates of Travel:
From: Anywhere in Canada or US To: Toronto From: April 1, 2017 To: April 5, 2017
From: Toronto To: Anywhere in Canada or US From: April 4, 2017 To: April 8, 2017


Book Now

 

Air Canada is pleased to offer 15% off of flex fares for the RESI on MaRS Conference in Toronto. Discounts apply 7 days pre & post conference, simply go to aircanada.com and add the code VDKVFRG1 in the promotion box and the discounts will calculate automatically.

Book Now